HuGE Literature Finder
Records
1
-
11
| Mutational landscape of primary and recurrent Ewing sarcoma. Contemporary oncology (Poznan, Poland) 2022 1 25 (4): 241-248. Jagodzi?ska-Mucha Paulina, Sobczuk Pawe?, Miku?a Micha?, Raciborska Anna, Dawidowska Anna, Kulecka Maria, Bilska Katarzyna, Szumera-Cie?kiewicz Anna, Kluska Anna, Pi?tkowska Magdalena, Ba?abas Anna, Rutkowski Piotr, ?ugowska Iwo |
| Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer. Frontiers in genetics 2022 12 13 1026871. Wu Xin, Wang Qiong, Liu Peifa, Sun Linde, Wang |
| Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer. International journal of radiation oncology, biology, physics 2020 2 107 (2): 353-359. Schlosser Shir, Rabinovitch Rachel, Shatz Zina, Galper Shira, Shahadi-Dromi Ilanit, Finkel Sara, Jacobson Galia, Rasco Adi, Friedman Eitan, Laitman Yael, Evron Ella, Bernstein Rinat, Weiss Ilana, Sklair-Levy Miri, Ben-David Merav |
| Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers. Cancer 2019 Mar 125 (5): 698-703. Laitman Yael, Michaelson-Cohen Rachel, Levi Einat, Chen-Shtoyerman Rakefet, Reish Orit, Josefsberg Ben-Yehoshua Sagi, Bernstein-Molho Rinat, Keinan-Boker Lital, Rosengarten Ora, Silverman Barbara G, Perri Tamar, Korach Jacob, Mor Pnina, Ephrat Ben-Baruch Noa, Levy Lahad Ephrat, Friedman Eitan, |
| Breast cancer cases of female patients under 35 years of age in Togo: A series of 158 cases. Molecular and clinical oncology 2017 12 7 (6): 1125-1129. Darré Tchin, Tchaou Mazamaesso, Folligan Koué, Amadou Abdoulatif, N'Timon Bidamin, Sonhaye Lantam, Aboubakari Abdoul-Samadou, Amégbor Koffi, Akpadza Koffi, Napo Koura Ga |
| Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma. Anticancer research 2017 04 37 (4): 1729-1735. Okamoto Tatsuro, Kohno Mikihiro, Ito Kensaku, Takada Kazuki, Katsura Masakazu, Morodomi Yosuke, Toyokawa Gouji, Shoji Fumihiro, Maehara Yoshihi |
| BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients. British journal of cancer 2015 Feb 112 (4): 688-92. Laroche-Clary A, Chaire V, Le Morvan V, Neuville A, Bertucci F, Salas S, Sanfilippo R, Pourquier P, Italiano |
| TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson |
| Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations. Breast cancer research and treatment 2013 Jul 140 (1): 207-11. Kadouri Luna, Sagi Michal, Goldberg Yael, Lerer Israela, Hamburger Tamar, Peretz Tam |
| Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast cancer research : BCR 2012 14 (2): R66. Lee Daphne S C, Yoon Sook-Yee, Looi Lai Meng, Kang Peter, Kang In Nee, Sivanandan Kavitta, Ariffin Hany, Thong Meow Keong, Chin Kin Fah, Mohd Taib Nur Aishah, Yip Cheng-Har, Teo Soo-Hwa |
| ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma. Cancer 2011 Aug 117 (15): 3445-56. Italiano Antoine, Laurand Armelle, Laroche Audrey, Casali Paolo, Sanfilippo Roberta, Le Cesne Axel, Judson Ian, Blay Jean-Yves, Ray-Coquard Isabelle, Bui Binh, Coindre Jean-Michel, Nieto Antonio, Tercero Juan-Carlos, Jimeno Jose, Robert Jacques, Pourquier Philip |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: